Cargando…
A synDNA vaccine delivering neoAg collections controls heterogenous, multifocal murine lung and ovarian tumors via robust T cell generation
Neoantigens are tumor-specific antigens that arise due to somatic mutations in the DNA of tumor cells. They represent ideal targets for cancer immunotherapy since there is minimal risk for on-target, off-tumor toxicities. Additionally, these are foreign antigens that should be immunogenic due to lac...
Autores principales: | Bhojnagarwala, Pratik S., Perales-Puchalt, Alfredo, Cooch, Neil, Sardesai, Niranjan Y., Weiner, David B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166642/ https://www.ncbi.nlm.nih.gov/pubmed/34141866 http://dx.doi.org/10.1016/j.omto.2021.04.005 |
Ejemplares similares
-
Strategic Variants of CSP Delivered as SynDNA Vaccines Demonstrate Heterogeneity of Immunogenicity and Protection from Plasmodium Infection in a Murine Model
por: Reeder, Sophia M., et al.
Publicado: (2021) -
synDNA—a Synthetic DNA Spike-in Method for Absolute Quantification of Shotgun Metagenomic Sequencing
por: Zaramela, Livia S., et al.
Publicado: (2022) -
Mucosal chemokine adjuvant enhances synDNA vaccine-mediated responses to SARS-CoV-2 and provides heterologous protection in vivo
por: Gary, Ebony N., et al.
Publicado: (2022) -
A novel mouse AAV6 hACE2 transduction model of wild-type SARS-CoV-2 infection studied using synDNA immunogens
por: Gary, Ebony N., et al.
Publicado: (2021) -
NEOage clocks - epigenetic clocks to estimate post-menstrual and postnatal age in preterm infants
por: Graw, Stefan, et al.
Publicado: (2021)